Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study

R. Louis (Liège, Belgium), P. Chanez (Marseille, France), F. Menzella (Reggio Emilia, Italy), G. Philteos (Saskatchewan, Canada), B. Cosio (Palma de Mallorca, Spain), N. Lugogo (Ann Arbor, United States of America), G. De Luiz (Barcelona, Spain), T. Harrison (Nottingham , United Kingdom), A. Burden (Cambridge, United Kingdom), T. Adlington (Cambridge, United Kingdom), N. Keeling (Gothenburg, Sweden), J. Kwiatek (Wilmington, United States of America), E. Garcia Gil (Barcelona, Spain)

Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Louis (Liège, Belgium), P. Chanez (Marseille, France), F. Menzella (Reggio Emilia, Italy), G. Philteos (Saskatchewan, Canada), B. Cosio (Palma de Mallorca, Spain), N. Lugogo (Ann Arbor, United States of America), G. De Luiz (Barcelona, Spain), T. Harrison (Nottingham , United Kingdom), A. Burden (Cambridge, United Kingdom), T. Adlington (Cambridge, United Kingdom), N. Keeling (Gothenburg, Sweden), J. Kwiatek (Wilmington, United States of America), E. Garcia Gil (Barcelona, Spain). Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study. 1114

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Late Breaking Abstract - WEAning From NonInvasive Ventilation – ‘WEANIV’ Study
Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation
Year: 2020



Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



Introduction to The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
Source: Eur Respir J 2002; 20: Suppl. 38, 426s
Year: 2002

Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019




Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019



Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group.
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018

Late Breaking Abstract - Prone-Positioning in Awake, Non-Intubated Patients with COVID-19 Hypoxemic Failure: A Single-Center Trial
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021


Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Source: Guideline 2020
Year: 2020

Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to  Fixed Dose Combination (FDC).
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Association Between Pain Level and Fatigue Level with Activities of Daily Living in Lung Cancer Patients Receiving Inpatient Cancer Therapy: A Pilot Study
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Late Breaking Abstract - Severe Asthma Prevalence, Care Pathways, and Health Care Resource Utilization in France
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Impact of Improved Cookstove Usage on Lung Function in Congolese Refugees: A Prospective Cohort Study.
Source: International Congress 2017 – The air indoor air pollution
Year: 2017



Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019



Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



Book Review: Sleep Disordered Breathing in Children: A Comprehensive Clinical Guide to Evaluation and Treatment
Source: Eur Respir Rev 2013; 22: 420
Year: 2013


Treatment With Baricitinib for Patients With COVID-19 Infections: A Case-Series Study
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021